Background and Purpose—Heart failure (HF) in patients with acute ischemic stroke
constitutes the source of various detrimental pathophysiologic mechanisms including …

Background Heart failure (HF) is the second most important cardiac risk factor for stroke after
atrial fibrillation (AF). Few data are available on mechanical thrombectomy (MT) in acute …

(1) Background: Little is known about how left ventricular systolic dysfunction (LVSD) affects
functional and clinical outcomes in acute ischemic stroke (AIS) patients undergoing …

Background. Since heart failure (HF) and ischemic stroke have common risk factors, their
concurrent occurrence is likely. Strokes in HF patients could be life‐threatening and lead to …

As few studies have reported the impact of lower left ventricular ejection fraction (LVEF) on
the prognosis of acute ischemic stroke (AIS) patients, we aimed to explore this through a …

Background The relationship between whole spectrum of Ejection fraction (EF) and
cardioembolic stroke (CES) outcome has not been fully described yet. Notably, it remains …

Background: Although intravenous recombinant tissue plasminogen activator (rt-PA)
thrombolysis is the most effective early treatment for acute ischemic stroke (AIS), outcomes …

Objective: Acute ischemic stroke (AIS) patients with congestive heart failure (HF) that present
with various risk factors are less likely to receive recombinant tissue plasminogen activator …

Heart failure (HF) is a major global cause of death with increasing absolute worldwide
numbers of HF patients. HF results from the interaction between cardiovascular aging with …

Background Atrial fibrillation (AF) and heart failure (HF) carry a poor prognosis in acute
ischaemic stroke (AIS). The impact of revascularisation therapies on outcomes in these …